Article

Knowledge and use of hormone replacement therapy among Polish women: estimates from a nationally representative study--HORTPOL 2002.

Department of Immunology of the Medical University of Gdańsk, ul. Debinki 1, 80-210 Gdańsk, Poland.
Maturitas (impact factor: 2.77). 02/2004; 47(1):31-7. pp.31-7
Source: PubMed

ABSTRACT To evaluate the knowledge about hormone replacement therapy (HRT) and the prevalence of its current use in Polish female population.
Cross-sectional survey on a representative sample of 1544 women between 18 and 87 years of age.
Almost half of the Polish women have heard of HRT. Depending on the education level, 26-38% of women knew that HRT alleviates the physical and psychological symptoms of menopause and 18-32% knew that HRT reduces the risk of developing osteoporosis. Forty-three percent of all the women with a higher level of education were aware that HRT increases the risk of breast and uterine cancer. The prevalence of current HRT use among women aged 45-64 was 12%. Women who had only basic education were less likely to use HRT than those with a medium and higher education level. Lack of information about HRT was the main cause of not using it. Forty-four percent of the perimenopausal women (age range 45-54 years) have never heard of HRT and 36% were never told by their healthcare providers that they could use it. Nineteen percent of perimenopausal women were not using HRT because they were afraid of the HRT related risks. Sixty-four percent of women who were using HRT were prescribed oral HRT preparations.
A fairly small proportion of Polish women currently uses HRT, largely because most remain poorly informed about the therapy.

0 0
 · 
0 Bookmarks
 · 
10 Views
  • Source
    Article: The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial.
    [show abstract] [hide abstract]
    ABSTRACT: With the exception of sexual functioning and weight, social and behavioural effects of postmenopausal hormone therapy (HT) have not been reported from trials. This paper reports such results from the EPHT-trial in Estonia. A randomized trial, with a blind and non-blind sub-trial in Estonia. From 1999-2001, 1778 women were recruited. The mean follow-up was 3.6 years. Women's experiences were asked in the first and final study year by mailed questionnaires (74 and 81% response rates). Comparisons of the groups were made by cross-tabulation and logistic regression, adjusting for age. There were no differences between the HT and non-HT groups in regard to being employed, the extent of social involvement or marital status or opinions on aging. There was no difference in the frequency of free-time exercise, or overweight. Some of the indicators suggested less sexual inactivity, but the differences were small. In a trial setting, postmenopausal hormone therapy did not influence work or social involvement or health behaviour.
    BMC Women s Health 07/2009; 9:16.

Keywords

age range 45-54 years
 
Cross-sectional survey
 
current HRT use
 
current use
 
education level
 
healthcare providers
 
higher education level
 
hormone replacement therapy
 
HRT alleviates
 
HRT increases
 
main cause
 
oral HRT preparations
 
perimenopausal women
 
Polish female population
 
Polish women
 
psychological symptoms
 
representative sample
 
use HRT
 
uterine cancer
 
Women